Published in Arch Intern Med on March 13, 2006
Too soon to give up: re-examining the value of advance directives. Am J Bioeth (2010) 5.71
Surviving surrogate decision-making: what helps and hampers the experience of making medical decisions for others. J Gen Intern Med (2007) 1.96
Substituted judgment: the limitations of autonomy in surrogate decision making. J Gen Intern Med (2008) 1.88
An empirical study of surrogates' preferred level of control over value-laden life support decisions in intensive care units. Am J Respir Crit Care Med (2010) 1.79
Scope and outcomes of surrogate decision making among hospitalized older adults. JAMA Intern Med (2014) 1.77
Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not? Intensive Care Med (2007) 1.76
Identifying family members who may struggle in the role of surrogate decision maker. Crit Care Med (2012) 1.75
Continuity of care and intensive care unit use at the end of life. Arch Intern Med (2009) 1.70
A scenario-based, randomized trial of patient values and functional prognosis on intensivist intent to discuss withdrawing life support. Crit Care Med (2014) 1.66
An advance directive redesigned to meet the literacy level of most adults: a randomized trial. Patient Educ Couns (2007) 1.63
Preferences versus practice: life-sustaining treatments in last months of life in long-term care. J Am Med Dir Assoc (2010) 1.58
Effect of a disease-specific planning intervention on surrogate understanding of patient goals for future medical treatment. J Am Geriatr Soc (2010) 1.55
Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology (2010) 1.52
Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manage (2012) 1.47
Surrogate consent for dementia research: a national survey of older Americans. Neurology (2009) 1.44
The association between treatment preferences and trajectories of care at the end-of-life. J Gen Intern Med (2007) 1.44
Advance Care Planning in Dementia: Do Family Carers Know the Treatment Preferences of People with Early Dementia? PLoS One (2016) 1.39
Is physician-assisted death in anyone's best interest? Yes. Can Fam Physician (2015) 1.36
Ethics review: 'Living wills' and intensive care--an overview of the American experience. Crit Care (2007) 1.23
How would terminally ill patients have others make decisions for them in the event of decisional incapacity? A longitudinal study. J Am Geriatr Soc (2007) 1.20
Physicians' experience with surrogate decision making for hospitalized adults. J Gen Intern Med (2009) 1.15
Just ask: discussing goals of care with patients in hospital with serious illness. CMAJ (2013) 1.14
Development of an interactive computer program for advance care planning. Health Expect (2008) 1.12
The need for safeguards in advance care planning. J Gen Intern Med (2012) 1.10
The evolution of health care advance planning law and policy. Milbank Q (2010) 1.07
Do Older Adults Know Their Spouses' End-of-Life Treatment Preferences? Res Aging (2009) 1.06
Decisions for others become less impulsive the further away they are on the family tree. PLoS One (2012) 1.05
Agreement between older persons and their surrogate decision-makers regarding participation in advance care planning. J Am Geriatr Soc (2011) 1.03
Augmenting communication and decision making in the intensive care unit with a cardiopulmonary resuscitation video decision support tool: a temporal intervention study. J Palliat Med (2012) 1.03
Promoting advance care planning as health behavior change: development of scales to assess Decisional Balance, Medical and Religious Beliefs, and Processes of Change. Patient Educ Couns (2011) 1.02
Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study. Support Care Cancer (2012) 0.99
How family caregivers' medical and moral assumptions influence decision making for patients in the vegetative state: a qualitative interview study. J Med Ethics (2012) 0.97
Opportunity lost: end-of-life discussions in cancer patients who die in the hospital. J Hosp Med (2012) 0.96
Surrogate and patient discrepancy regarding consent for critical care research. Crit Care Med (2012) 0.96
Estimating and communicating prognosis in advanced neurologic disease. Neurology (2013) 0.96
Missed opportunities: use of an end-of-life symptom management order protocol among inpatients dying expected deaths. J Palliat Med (2011) 0.96
Surrogate decision makers' understanding of dementia patients' prior wishes for end-of-life care. J Aging Health (2009) 0.92
Physicians' views on the importance of patient preferences in surrogate decision-making. J Am Geriatr Soc (2010) 0.92
The facilitated values history: helping surrogates make authentic decisions for incapacitated patients with advanced illness. Am J Respir Crit Care Med (2012) 0.91
Organ donation after acute brain death: addressing limitations of time and resources in the emergency department. Yale J Biol Med (2013) 0.91
Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol (2013) 0.90
Knowing loved ones' end-of-life health care wishes: attachment security predicts caregivers' accuracy. Health Psychol (2011) 0.89
The influence of age on the likelihood of receiving end-of-life care consistent with patient treatment preferences. J Palliat Med (2010) 0.89
The Impact of Late-Life Parental Death on Adult Sibling Relationships: Do Parents' Advance Directives Help or Hurt? Res Aging (2009) 0.89
Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Palliat Med (2010) 0.88
The ethics of informed consent in Alzheimer disease research. Nat Rev Neurol (2011) 0.88
A conceptual model of the role of communication in surrogate decision making for hospitalized adults. Patient Educ Couns (2011) 0.87
How important is 'accuracy' of surrogate decision-making for research participation? PLoS One (2013) 0.87
End-of-life care communications and shared decision-making in Norwegian nursing homes--experiences and perspectives of patients and relatives. BMC Geriatr (2015) 0.87
Family understanding of seriously-ill patient preferences for family involvement in healthcare decision making. J Gen Intern Med (2011) 0.87
Advance care planning in nursing homes and assisted living communities. J Am Med Dir Assoc (2009) 0.86
End-of-life decision-making confidence in surrogates of African-American dialysis patients is overly optimistic. J Palliat Med (2012) 0.85
Promoting advance planning for health care and research among older adults: a randomized controlled trial. BMC Med Ethics (2012) 0.84
Making decisions for hospitalized older adults: ethical factors considered by family surrogates. J Clin Ethics (2013) 0.84
Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol (2013) 0.83
Patient and Caregiver Incongruence in Advanced Heart Failure. Clin Nurs Res (2014) 0.82
Persistent problems in end-of-life planning among young- and middle-aged American couples. J Gerontol B Psychol Sci Soc Sci (2012) 0.82
Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer (2014) 0.82
To what extent are the wishes of a signatory reflected in their advance directive: a qualitative analysis. BMC Med Ethics (2014) 0.81
Reliability of an interactive computer program for advance care planning. J Palliat Med (2012) 0.81
The accuracy of surrogate decision makers: informed consent in hypothetical acute stroke scenarios. BMC Emerg Med (2013) 0.81
Qualitative evaluation of advanced care planning in early dementia (ACP-ED). PLoS One (2013) 0.81
Research priorities in geriatric palliative care: informal caregiving. J Palliat Med (2013) 0.81
Concordance of family and staff member reports about end of life in assisted living and nursing homes. Gerontologist (2009) 0.80
Recognizing, naming, and measuring a family intensive care unit syndrome. Ann Am Thorac Soc (2014) 0.80
Empirical fallacies in the debate on substituted judgment. Health Care Anal (2014) 0.80
Family factors in end-of-life decision-making: family conflict and proxy relationship. J Palliat Med (2011) 0.80
A qualitative analysis of the decision-making process for patients with severe lower leg trauma. Plast Reconstr Surg (2010) 0.80
Levels of Intervention: How Are They Used in Quebec Hospitals? J Bioeth Inq (2017) 0.79
Advance care planning - a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study. BMC Cancer (2016) 0.79
Accuracy of a decision aid for advance care planning: simulated end-of-life decision making. J Clin Ethics (2011) 0.79
Understanding Goals of Care Statements and Preferences among Patients and Their Surrogates in the Medical ICU. J Hosp Palliat Nurs (2012) 0.79
Using data to improve surrogate consent for clinical research with incapacitated adults. J Empir Res Hum Res Ethics (2012) 0.78
Should an elderly patient with stage V CKD and dementia be started on dialysis? Clin J Am Soc Nephrol (2013) 0.78
How should treatment decisions be made for incapacitated patients, and why? PLoS Med (2007) 0.78
An assessment of social diffusion in the Respecting Choices advance care planning program. Death Stud (2012) 0.78
Prior Advance Care Planning Is Associated with Less Decisional Conflict among Surrogates for Critically Ill Patients. Ann Am Thorac Soc (2015) 0.78
Improving medical decisions for incapacitated persons: does focusing on "accurate predictions" lead to an inaccurate picture? J Med Philos (2014) 0.77
Preventing life-sustaining treatment by default. Ann Fam Med (2011) 0.77
Conceptualizing surrogate decision making at end of life in the intensive care unit using cognitive task analysis. Nurs Outlook (2014) 0.77
Coaching Family Caregivers to Become Better Problem Solvers When Caring for Persons with Advanced Cancer. J Soc Work End Life Palliat Care (2016) 0.77
Surrogate utility estimation by long-term partners and unfamiliar dyads. Front Psychol (2015) 0.75
Beyond competence: advance directives in dementia research. Monash Bioeth Rev (2015) 0.75
Availability of Advance Care Planning Documentation for Older Emergency Department Patients: A Cross-Sectional Study. J Palliat Med (2016) 0.75
Engaging Patients With Advance Directives Using an Information Visualization Approach. J Gerontol Nurs (2015) 0.75
Depression of Family Caregivers Is Associated with Disagreements on Life-Sustaining Preferences for Treating Patients with Dementia. PLoS One (2015) 0.75
Surrogate decision making in neurocritical care. Continuum (Minneap Minn) (2012) 0.75
A Dyadic Perspective on Engagement in Advance Care Planning. J Am Geriatr Soc (2016) 0.75
Capacity issues and decision-making in dementia. Ann Indian Acad Neurol (2016) 0.75
The utility of standardized advance directives: the general practitioners' perspective. Med Health Care Philos (2016) 0.75
Advance Care Planning. Does It Benefit Surrogate Decision Makers in the Intensive Care Unit? Ann Am Thorac Soc (2015) 0.75
Making treatment decisions for oneself: weighing the value. Hastings Cent Rep (2014) 0.75
Perspectives of continuous renal replacement therapy in the intensive care unit: a paired survey study of patient, physician, and nurse views. BMC Nephrol (2015) 0.75
Gender-dependence of substituted judgment on quality of life in patients with dementia. BMC Neurol (2011) 0.75
Discussing goals of care for a delirious advanced cancer patient in the hospice setting. J Palliat Med (2013) 0.75
Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU. PLoS One (2016) 0.75
High-risk percutaneous coronary intervention in the era of public reporting: clinical and ethical considerations in the care of an elderly patient with critical left main disease and shock. Circulation (2014) 0.75
Clinical review: the role of the intensivist and the rapid response team in nosocomial end-of-life care. Crit Care (2013) 0.75
Intensive care unit strain should not rush physicians into making inappropriate decisions, but merely reduce the time to the right decisions being made. Ann Transl Med (2016) 0.75
What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis (2004) 9.65
Broad Consent for Research With Biological Samples: Workshop Conclusions. Am J Bioeth (2015) 8.99
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother (2008) 6.55
Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med (2004) 5.47
Comparison of "B" readers' interpretations of chest radiographs for asbestos related changes. Acad Radiol (2004) 4.71
How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA (2004) 4.65
Development in infants with autism spectrum disorders: a prospective study. J Child Psychol Psychiatry (2006) 3.54
Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry (2007) 3.29
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer. J Clin Oncol (2007) 3.23
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20
Research with stored biological samples: what do research participants want? Arch Intern Med (2005) 2.43
A family's request for complementary medicine after patient brain death. JAMA (2008) 2.27
Protecting communities in health research from exploitation. Bioethics (2006) 2.26
Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic. Am J Bioeth (2015) 2.20
Use of a patient preference predictor to help make medical decisions for incapacitated patients. J Med Philos (2014) 2.18
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. Clin Cancer Res (2005) 2.10
Deception in research on the placebo effect. PLoS Med (2005) 2.05
Treatment decision making for incapacitated patients: is development and use of a patient preference predictor feasible? J Med Philos (2014) 2.05
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood (2011) 2.03
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res (2010) 1.93
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis (2007) 1.91
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer. Clin Cancer Res (2009) 1.85
Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A (2006) 1.80
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach. Ann Intern Med (2006) 1.73
Ancillary care obligations of medical researchers. JAMA (2009) 1.70
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med (2012) 1.68
Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med (2013) 1.66
Response to joint attention in toddlers at risk for autism spectrum disorder: a prospective study. J Autism Dev Disord (2007) 1.65
Is emergency research without initial consent justified?: the consent substitute model. Arch Intern Med (2010) 1.65
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.62
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood (2006) 1.59
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Prevalence and determinants of physician bedside rationing: data from Europe. J Gen Intern Med (2006) 1.57
Clinician integrity and limits to patient autonomy. JAMA (2011) 1.55
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest (2011) 1.54
Medical decision making for patients without surrogates. Arch Intern Med (2007) 1.51
ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett (2010) 1.50
Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics (2013) 1.44
A proposal and prototype for a Research Risk Repository to improve the protection of research participants. Clin Trials (2011) 1.44
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes. Leuk Res (2008) 1.43
Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate. Urology (2010) 1.43
A framework for risk-benefit evaluations in biomedical research. Kennedy Inst Ethics J (2011) 1.42
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease. J Natl Cancer Inst (2007) 1.41
Institutional review board practices regarding assent in pediatric research. Pediatrics (2004) 1.40
Does random treatment assignment cause harm to research participants? PLoS Med (2006) 1.39
Dissolving the dilemma over forced treatment. Lancet (2005) 1.39
Ductal access for prevention and therapy of mammary tumors. Cancer Res (2006) 1.38
The moral duty to buy health insurance. JAMA (2012) 1.38
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res (2004) 1.35
Does it pay to pay? A randomized trial of prepaid financial incentives and lottery incentives in surveys of nonphysician healthcare professionals. Nurs Res (2005) 1.32
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. J Clin Oncol (2008) 1.30
Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc Natl Acad Sci U S A (2007) 1.22
Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey. Ann Intern Med (2015) 1.20
Quality of parental consent in a Ugandan malaria study. Am J Public Health (2005) 1.19
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther (2006) 1.19
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS One (2011) 1.17
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res (2010) 1.15
Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicol Sci (2005) 1.14
Debriefing and accountability in deceptive research. Kennedy Inst Ethics J (2008) 1.13
The quality of informed consent in a clinical research study in Thailand. IRB (2005) 1.13
Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2006) 1.12
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res (2011) 1.10
Evaluating the risks of clinical research. JAMA (2010) 1.09
Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. Proc Natl Acad Sci U S A (2004) 1.09
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab (2012) 1.08
Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes Control (2009) 1.08
Is there a role for assent or dissent in animal research? Camb Q Healthc Ethics (2015) 1.07
Risks and benefits associated with novel phase 1 oncology trial designs. Cancer (2007) 1.07
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. Cancer Biol Ther (2004) 1.06
Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review. J Clin Oncol (2007) 1.05
How do children and parents make decisions about pediatric clinical research? J Pediatr Hematol Oncol (2008) 1.03
Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res (2008) 1.01
When do the federal regulations allow placebo-controlled trials in children? J Pediatr (2003) 1.01
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method. Clin Trials (2012) 1.01
The ethics of phase 0 oncology trials. Clin Cancer Res (2008) 1.01
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer (2010) 1.00
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant (2006) 0.99
Symptoms, supportive care needs, and function in cancer patients: how are they related? Qual Life Res (2008) 0.99
Effect of DNA methylation on identification of aggressive prostate cancer. Urology (2008) 0.98
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading. Stat Med (2011) 0.98
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer (2009) 0.98
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy. Urology (2007) 0.97
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. Blood (2014) 0.96
Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol (2007) 0.96
The relevance of empirical research in bioethics. Schizophr Bull (2005) 0.95
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling. Cancer Res (2006) 0.94
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors. Hum Mol Genet (2005) 0.94
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant (2005) 0.94
Post-trial access to tested interventions: the views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study. AIDS Res Hum Retroviruses (2006) 0.94
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol (2012) 0.94
High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Ann Epidemiol (2012) 0.94
Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina. Prog Community Health Partnersh (2012) 0.94
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features. Clin Cancer Res (2008) 0.93
Research advance directives: protection or obstacle? Am J Psychiatry (2005) 0.93
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer. Mol Cancer Ther (2007) 0.93
Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessation. Nicotine Tob Res (2009) 0.93
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. Clin Cancer Res (2011) 0.91